Cargando…
Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay
The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500353/ https://www.ncbi.nlm.nih.gov/pubmed/28683141 http://dx.doi.org/10.1371/journal.pone.0180669 |
_version_ | 1783248615998750720 |
---|---|
author | Lebani, Kebaneilwe Jones, Martina L. Watterson, Daniel Ranzoni, Andrea Traves, Renee J. Young, Paul R. Mahler, Stephen M. |
author_facet | Lebani, Kebaneilwe Jones, Martina L. Watterson, Daniel Ranzoni, Andrea Traves, Renee J. Young, Paul R. Mahler, Stephen M. |
author_sort | Lebani, Kebaneilwe |
collection | PubMed |
description | The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Non-structural protein 1 (NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay (ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability. |
format | Online Article Text |
id | pubmed-5500353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55003532017-07-11 Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay Lebani, Kebaneilwe Jones, Martina L. Watterson, Daniel Ranzoni, Andrea Traves, Renee J. Young, Paul R. Mahler, Stephen M. PLoS One Research Article The multidimensional nature of dengue virus (DENV) infections, which can be caused by four distinct serotypes of the virus, complicates the sensitivity of assays designed for the diagnosis of infection. Different viral markers can be optimally detected at different stages of infection. Of particular clinical importance is the early identification of infection, which is pivotal for disease management and the development of blood screening assays. Non-structural protein 1 (NS1) is an early surrogate marker of infection and its detection in serum coincides with detectable viraemia. The aim of this work was to isolate and characterise serotype-specific monoclonal antibodies that bind to NS1 for each of the four DENV serotypes. This was achieved using phage display and a subtractive biopanning strategy to direct the antibody selection towards serotype-specific epitopes. This antibody isolation strategy has advantages over immunisation techniques where it is difficult to avoid antibody responses to cross-reactive, immunodominant epitopes. Serotype specificity to recombinant antigen for each of the antibodies was confirmed by Enzyme Linked Immunosorbent Assay (ELISA) and Surface Plasmon Resonance. Confirmation of binding to native DENV NS1 was achieved using ELISA and immunofluorescence assay on DENV infected Vero cells. No cross-reactivity with Zika or Kunjin viruses was observed. A previously isolated pan-reactive antibody that binds to an immunodominant epitope was able to pair with each of the serotype-specific antibodies in a sandwich ELISA, indicating that the serotype specific antibodies bind to epitopes which are all spatially distinct from the immunodominant epitope. These antibodies were suitable for use in a multiplexed assay for simultaneous detection and serotyping of DENV NS1 in human serum. This work demonstrates that phage display coupled with novel biopanning strategies is a valuable in vitro methodology for isolation of binders that can discern amongst antigens with high homology for diagnostic applicability. Public Library of Science 2017-07-06 /pmc/articles/PMC5500353/ /pubmed/28683141 http://dx.doi.org/10.1371/journal.pone.0180669 Text en © 2017 Lebani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Lebani, Kebaneilwe Jones, Martina L. Watterson, Daniel Ranzoni, Andrea Traves, Renee J. Young, Paul R. Mahler, Stephen M. Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title | Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title_full | Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title_fullStr | Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title_full_unstemmed | Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title_short | Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
title_sort | isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500353/ https://www.ncbi.nlm.nih.gov/pubmed/28683141 http://dx.doi.org/10.1371/journal.pone.0180669 |
work_keys_str_mv | AT lebanikebaneilwe isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT jonesmartinal isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT wattersondaniel isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT ranzoniandrea isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT travesreneej isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT youngpaulr isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay AT mahlerstephenm isolationofserotypespecificantibodiesagainstdenguevirusnonstructuralprotein1usingphagedisplayandapplicationinamultiplexedserotypingassay |